Adami S - Search Results

1

Efficacy and safety of ibandronate given by intravenous injection once every 3 months.

Adami S, Felsenberg D, Christiansen C, Robinson J, Lorenc RS, Mahoney P, Coutant K, Schimmer RC, Delmas PD. Adami S, et al. Bone. 2004 May;34(5):881-9. doi: 10.1016/j.bone.2004.01.007. Bone. 2004. PMID: 15121020 Clinical Trial.

2

Efficacy and tolerability of once-monthly oral ibandronate in postmenopausal osteoporosis: 2 year results from the MOBILE study.

Reginster JY, Adami S, Lakatos P, Greenwald M, Stepan JJ, Silverman SL, Christiansen C, Rowell L, Mairon N, Bonvoisin B, Drezner MK, Emkey R, Felsenberg D, Cooper C, Delmas PD, Miller PD. Reginster JY, et al. Among authors: adami s. Ann Rheum Dis. 2006 May;65(5):654-61. doi: 10.1136/ard.2005.044958. Epub 2005 Dec 8. Ann Rheum Dis. 2006. PMID: 16339289 Free PMC article. Clinical Trial.

3

Intravenous intermittent neridronate in the treatment of postmenopausal osteoporosis.

Braga V, Gatti D, Colapietro F, Battaglia E, Righetti D, Prizzi R, Rossini M, Adami S. Braga V, et al. Among authors: adami s. Bone. 2003 Sep;33(3):342-5. doi: 10.1016/s8756-3282(03)00084-x. Bone. 2003. PMID: 13678775 Clinical Trial.

4

Effect of raloxifene after recombinant teriparatide [hPTH(1-34)] treatment in postmenopausal women with osteoporosis.

Adami S, San Martin J, Muñoz-Torres M, Econs MJ, Xie L, Dalsky GP, McClung M, Felsenberg D, Brown JP, Brandi ML, Sipos A. Adami S, et al. Osteoporos Int. 2008 Jan;19(1):87-94. doi: 10.1007/s00198-007-0485-y. Epub 2007 Oct 16. Osteoporos Int. 2008. PMID: 17938984 Clinical Trial.

5

Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.

Adami S. Adami S. Bone. 2006 Feb;38(2 Suppl 1):23-7. doi: 10.1016/j.bone.2005.08.028. Epub 2006 Jan 24. Bone. 2006. PMID: 16434247 Clinical Trial.

6

Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density.

Eastell R, Black DM, Boonen S, Adami S, Felsenberg D, Lippuner K, Cummings SR, Delmas PD, Palermo L, Mesenbrink P, Cauley JA; HORIZON Pivotal Fracture Trial. Eastell R, et al. Among authors: adami s. J Clin Endocrinol Metab. 2009 Sep;94(9):3215-25. doi: 10.1210/jc.2008-2765. Epub 2009 Jun 30. J Clin Endocrinol Metab. 2009. PMID: 19567517 Free PMC article.

7

Intramuscular clodronate therapy in postmenopausal osteoporosis.

Rossini M, Braga V, Gatti D, Gerardi D, Zamberlan N, Adami S. Rossini M, et al. Among authors: adami s. Bone. 1999 Feb;24(2):125-9. doi: 10.1016/s8756-3282(98)00154-9. Bone. 1999. PMID: 9951781 Clinical Trial.

8

Effects of two intermittent alendronate regimens in the prevention or treatment of postmenopausal osteoporosis.

Rossini M, Gatti D, Girardello S, Braga V, James G, Adami S. Rossini M, et al. Among authors: adami s. Bone. 2000 Jul;27(1):119-22. doi: 10.1016/s8756-3282(00)00291-x. Bone. 2000. PMID: 10865218 Clinical Trial.

9

Ibandronate: new options in the treatment of osteoporosis.

Adami S, Viapiana O. Adami S, et al. Drugs Today (Barc). 2003 Nov;39(11):877-86. doi: 10.1358/dot.2003.39.11.799465. Drugs Today (Barc). 2003. PMID: 14702133 Review.

10

Effects of tibolone and raloxifene on bone mineral density in osteopenic postmenopausal women.

Delmas PD, Davis SR, Hensen J, Adami S, van Os S, Nijland EA. Delmas PD, et al. Among authors: adami s. Osteoporos Int. 2008 Aug;19(8):1153-60. doi: 10.1007/s00198-007-0545-3. Epub 2008 Feb 7. Osteoporos Int. 2008. PMID: 18256777 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

387 results

Search Page

Filters